Interestingly, because the presence of NAFLD was found not to correlate with age, sex, degree of obesity, blood lipids, HOMA-IR, and therapy by statins or IGF1, the data were reported by Prof. Laron to be ‘not fitting with present theories of the development of fatty liver (29)’. The gene discussed is IGF1; the disease is obesity disorder.